Kim, Christine Y.
Luo, Lan
Yu, Qiping
Mirallave, Ana
Saunders-Pullman, Rachel
Lipton, Richard B.
Louis, Elan D.
Pullman, Seth L. http://orcid.org/0000-0003-1604-7527
Funding for this research was provided by:
National Institutes of Health (R01 NS042859, R01 NS088257, T32-NS07153, R01 NS042859, U01NS094148-01, U01NS094148-01, AG03949)
Michael J. Fox Foundation for Parkinson's Research
Parkinson's Disease Foundation (PG005860-31, PG005860-31, PG005860-31)
Article History
First Online: 11 September 2018
Compliance with Ethical Standards
: The study was conducted in accordance with the Institutional Review Board of Albert Einstein College of Medicine. Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Stock Ownership: eNeura Therapeutics (RBL).Consultancies: Consultant to Denali Therapeutics (RS-P).Expert Testimony: NONE.Advisory Boards: Dystonia Medical Research Foundation: Musicians with Dystonia, Scientific Advisory Board (SP); Tremor and Other Hyperkinetic Movement Disorders, Editorial Board (SP); National Headache Foundation (RBL), Neurology and the National Headache Foundation (RBL).Employment: Columbia University Medical Center (CK, LL, SP, QY); Yale School of Medicine (EL); Queen’s Hospital, Barking Redbridge and Havering Trust, Romford, London UK (AM), Mount Sinai Beth Israel, Icahn School of Medicine Mount Sinai (RS-P), Albert Einstein College of Medicine (RBL).Partnerships: NONE.Contracts: Consultant Clinical Neurophysiology permanent staff (AM).Honoraria: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKlein, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta (all RBL).Royalties: Wolff’s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa (RBL).Grants: NIH R01 NS042859 (SP); NIH T32 NS07153 (LL); NINDS R01 NS094607 (EL: principal investigator), NINDS R01 NS085136 (EL: principal investigator), NINDS R01 NS073872 (EL: principal investigator), NINDS R01 NS085136 (EL: principal investigator), NINDS R01 NS088257 (EL: principal investigator); Claire O’Neil Essential Tremor Research Fund (Yale University) (EL); Michael J. Fox Foundation for Parkinson’s Research, Edmund J. Safra Fellowship (CK); Parkinson Disease Foundation (LL, SP, QY); Dystonia Medical Research Foundation James C. Kilik Memorial Research Award (CK); Smart Foundation Gift for Parkinson’s Disease Research (CK); National Institutes of Health U01NS094148-01 (RS-P and RBL) and AG03949 (RBL), PO1 AG003949 (RBL; program director), 5 U10 NS077308 (RBL: PI), 1RO1 AG042595 (RBL; investigator), RO1 NS082432 (EBL: investigator), K23 NS09610 (RBL: mentor), and K23 AG049466 (RBL: mentor), the National Migraine Headache Foundation (RBL).